Alcohol and the Cardiovascular System: A Double-Edged Sword

被引:25
|
作者
Katsiki, Niki [1 ]
Tziomalos, Konstantinos [2 ]
Mikhailidis, Dimitri P. [3 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Hippokration Hosp, Propedeut Dept Internal Med 2, GR-54006 Thessaloniki, Greece
[2] UCL, Sch Med, Propedeut Dept Internal Med 1, AHEPA Hosp, London NW3 2QG, England
[3] UCL, Sch Med, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
关键词
Alcohol; cardiovascular disease; cardiovascular risk factors; diabetes; lipids; metabolic syndrome; statins; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; FATTY LIVER-DISEASE; RED WINE CONSUMPTION; C-REACTIVE PROTEIN; PERIPHERAL ARTERIAL-DISEASE; ACUTE MYOCARDIAL-INFARCTION; SLEEP-APNEA SYNDROME; LIFE-STYLE FACTORS; MODERATE ALCOHOL;
D O I
10.2174/1381612820666140620125741
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Low to moderate alcohol intake has been associated with beneficial effects on the heart and the vasculature, including improvements in several established and emerging cardiovascular disease (CVD) risk factors as well as reduced risk for several metabolic diseases, CVD morbidity and mortality. Binge and heavy drinking exert the opposite effects, leading to increased risks for all the above conditions. With regard to beverage type, there is some evidence supporting red wine superiority in cardioprotection, although other beverages have also been reported to exert beneficial metabolic and vascular effects when consumed in moderate amounts. In this narrative review we discuss the associations between alcohol consumption and CVD morbidity and mortality. Alcohol-induced effects on established and emerging CVD risk factors are also discussed taking into consideration different drinking patterns. Physicians should screen for excessive alcohol use and advise individuals to limit their alcohol intake to moderate amounts (up to 20-30 g/day for men and 10-20 g/day for women), preferably consumed with meals. The question of whether alcohol intake should be encouraged as a measure to prevent CVD remains unanswered.
引用
收藏
页码:6276 / 6288
页数:13
相关论文
共 50 条
  • [21] Ketones: the double-edged sword of SGLT2 inhibitors?
    Lupsa, Beatrice C.
    Kibbey, Richard G.
    Inzucchi, Silvio E.
    DIABETOLOGIA, 2023, 66 (01) : 23 - 32
  • [22] Fun in the Workplace and Employee Substance Use: A Double-Edged Sword?
    Tews, Michael J.
    Yu, Heyao
    Pons, Sydney T.
    JOURNAL OF DRUG ISSUES, 2025, 55 (01) : 104 - 118
  • [23] Twist1: A Double-Edged Sword in Kidney Diseases
    Ren, Jiafa
    Crowley, Steven D.
    KIDNEY DISEASES, 2020, 6 (04) : 247 - 257
  • [24] The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
    Wehedy, Eman
    Shatat, Ibrahim F.
    Al Khodor, Souhaila
    FRONTIERS IN MEDICINE, 2022, 8
  • [25] Caspase-8, a Double-Edged Sword for EPC Functioning
    Xiao, Qingzhong
    Xu, Qingbo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (04) : 444 - 446
  • [26] Omega-3: a double-edged sword for autoimmune diseases
    Wu, Guo-Cui
    Xu, Xiao-Di
    Huang, Qiong
    Wu, Hua
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (02) : 289 - 290
  • [27] Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
    Qi, Xiao-Yan
    Qu, Shun-Lin
    Xiong, Wen-Hao
    Rom, Oren
    Chang, Lin
    Jiang, Zhi-Sheng
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [28] Post-Infarction Inflammation and Left Ventricular emodeling - A Double-Edged Sword
    Anzai, Toshihisa
    CIRCULATION JOURNAL, 2013, 77 (03) : 580 - 587
  • [29] Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword
    Vlahakos, Demetrios V.
    Tsioufis, Costas
    Manolis, Athanasios
    Filippatos, Gerasimos
    Marathias, Katerina P.
    Papademetriou, Vasilios
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2019, 37 (11) : 2145 - 2153
  • [30] The double-edged sword of mechanical ventilation for patients with cardiogenic shock
    Champion, Sebastien
    CARDIOLOGY JOURNAL, 2014, 21 (04) : 449 - 449